Streetwise Reports' Article Archives — January 2012 back to current month (2)

Hepatitis C and Orphan Diseases Driving Big Biotech Potential: Geoff Meacham (01/31/2012)

It may seem counterintuitive that rare diseases might actually be biotech growth drivers, but Senior Analyst and Managing Director Geoff Meacham of JPMorgan Chase makes just that case. In this exclusive interview with The Life Sciences Report, Meacham lays out his premise that hepatitis C and orphan disease drugs can cure the woes of growth-starved investors.

more>

Driving Value for Pharma and Biotech Companies: Insights from Biotech Showcase 2012 (01/20/2012)

The 2012 Biotech Showcase investor conference in San Francisco drew a record number of life science interests from all over the world.

more>

More Archives

2024Feb Jan

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes